- The key vendors in the global peripheral vascular devices market are Abbott Laboratories Ltd., Boston Scientific Corp., C. R. Bard Inc., Cordis Corp. and Medtronic Inc.
London, 08 May 2015: Technavio, an independent tech-focused global research firm, has announced the publication of its market research report on the global peripheral vascular devices market 2015-2019. One of the latest trends emerging in the market is the growing use of bio-absorbable stents. The introduction of these new stents is expected to increase its usage in peripheral interventions, as they have the potential to eliminate the negative issues of durable polymer stents, thus inducing a significant shift in the treatment of PAD. The global peripheral vascular devices market is expected to grow at a CAGR of 7.29% during the forecast period of 2014-2019.
Excessive smoking, hypertension, high cholesterol and diabetes are the primary causes of peripheral vascular diseases. Genetic and co-morbid factors are also the major contributors. Therefore, there is a rise in the demand for peripheral vascular devices.
“With the emergence of drug coated balloon PTA catheters, the amount of blockage regrowth in the arteries can be controlled to a great extent. They are also an alternative to the placement of a permanent implant or scaffold in the blocked artery,” says Faisal Ghaus, Vice President of Technavio Research.
“The outer surface of the catheter’s balloon is coated with the drug paclitaxel that helps prevent arteries from narrowing again after the procedure.”
To define the market conditions in the next 3-4 years, Technavio analysts have conducted in-depth analysis of the impact of market drivers, challenges and trends featuring data on product segmentations, vendor shares, growth rate by revenue and an evaluation of the different buying criteria in the order of importance.
https://www.technavio.com/%3Cp%3EIf%20you%20are%20interested%20in%20more%…
